Biosyent: Top 25 Undervalued Dividend Stocks on TSX-V (RX)
Biosyent is now ranked among the top 10 undervalued small cap dividend-paying stocks on the TSX Venture Exchange (TSX-V).
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below).
- Small, micro and nano group market capitalization (<10B)
Stocks in this category are held primarily for potential income and capital appreciation. Dividend stocks showing a higher valuation than their current price have both potential upside and ability to sustain or grow their dividend.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| UFC | Urbanfund | 0.80 | 0.87 | 0.07 (9.2%) | 3360 | 48.5 | 6.3 | 6.5 |
| RX | Biosyent | 10.85 | 11.00 | 0.15 (1.4%) | 5162 | 128.0 | 1.6 | 18.2 |
| LPC | Lorne Park Capital | 1.30 | 1.31 | 0.01 (0.7%) | 72.4 | 2.2 | 40.6 | |
| MAR-UN | Marwest Apartment | 0.79 | 1.18 | 0.39 (49.5%) | 5757 | 7.0 | 2.0 | 1.2 |
| ORC-B | Orca Energy Group | 3.06 | 4.82 | 1.76 (57.6%) | 2736 | 60.5 | 13.3 | 14.8 |
| PINE-UN | Pine Trail | 0.03 | 0.03 | 0.01 (26.5%) | 3750 | 0.9 | 6.0 | 20.3 |
| SRES | Sun Residential REIT | 0.04 | 0.06 | 0.02 (47.7%) | 164542 | 8.1 | 9.5 | 0.0 |
| BCF | Builders Capital Mortgage | 9.00 | 9.42 | 0.42 (4.7%) | 1273 | 28.4 | 8.9 | 8.7 |
| NXLV | NexLiving Communities | 1.93 | 2.98 | 1.05 (54.3%) | 2022 | 32.4 | 2.0 | 6.7 |
| FDI | Findev | 0.41 | 0.46 | 0.05 (12.4%) | 1127 | 11.7 | 7.3 | 5.9 |
All data provided as of June 30, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Companies included above paid a dividend in the last 12-months.
Biosyent
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.
Biosyent is listed under RX on the TSX Venture Exchange.
StockCalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
